Atlas Trials

Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RS

Clinical trial NCT06006949 · UNKNOWN

Trial details

NCT number
NCT06006949
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2023-08-01
Primary completion
2024-08-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.